DEADLINE THIS WEEK: Berger Montague Advises Super Micro Computer (NASDAQ: SMCI) Investors to Contact the Firm Before October 29, 2024
PHILADELPHIA, Oct. 27, 2024 (GLOBE NEWSWIRE) — Securities fraud lawsuits have been filed against Super Micro Computer, Inc. (“Super Micro” or the “Company”) (NASDAQ: SMCI). The lawsuits have been filed
ECARX Powers Global Launch of the smart #5 Premium Mid-Size SUV
SHANGHAI, Oct. 27, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, in partnership with AMD, the high performance and adaptive computing
X Empire’s Token Landed on Bybit with a Splash: Bybit Breaks Airdrop Records and Offers 920,000,000 X in Rewards
DUBAI, United Arab Emirates, Oct. 27, 2024 (GLOBE NEWSWIRE) — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has listed the X Empire Token, $X, on Oct. 24 at
Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024
The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the last dose of felzartamab Felzartamab, an investigational anti-CD38 monoclonal
Novartis oral Fabhalta® (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial
New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1 Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope – a key measure of kidney function
Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024
Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to prevent kidney failure in patients with IgAN; Long-term results from the ORIGIN Phase 2b study
WEBTOON (NASDAQ: WBTN) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit
PHILADELPHIA, Oct. 26, 2024 (GLOBE NEWSWIRE) — A securities class action lawsuit has been filed against WEBTOON Entertainment Inc. (“WEBTOON” or the “Company”) (NASDAQ: WBTN). The lawsuit has been filed
ICONS Highlights Rally to Support University of Nevada Reno Women’s Volleyball Team in Stand for Justice and Fair Play on the Court
Washington, DC, Oct. 26, 2024 (GLOBE NEWSWIRE) — IMMEDIATE RELEASE MEDIA ALERT Hey NCAA & Mountain West!!! Women’s Sports are for Women Only ICONS Highlights Rally to Support University of
Travere Therapeutics Presents Data Reinforcing Clinical Benefit of FILSPARI® (Sparsentan) in IgAN and Late-Breaking Presentation in FSGS at ASN Kidney Week 2024
Nearly 60% of patients with IgAN in the SPARTAN Study achieved complete remission when using FILSPARI as first-line treatment SPARTACUS Study, PROTECT open-label extension, and real-world evidence presentations highlight initial
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024
Vivoryon Therapeutics N.V. Presents Outstanding Phase 2b Results of Varoglutamstat on Kidney Function at ASN Kidney Week 2024 Selected for late-breaking oral presentation at ASN kidney week, the world’s premier
CORRECTION – Sift Reinvents Account Takeover Prevention Across the Consumer Journey, Integrates with Leading CIAM Platforms
SAN FRANCISCO, Oct. 25, 2024 (GLOBE NEWSWIRE) — In a release issued on October 24, 2024 under the same headline by SIFT, please note that in the sub headline and first
El Pollo Loco Turns Up The Heat with Exclusive Mango Habanero Flavor Test
COSTA MESA, Calif., Oct. 25, 2024 (GLOBE NEWSWIRE) — El Pollo Loco, the nation’s leading fire-grilled chicken restaurant, is turning up the heat with a limited-time test of its all-new
Groundbreaking Machine Learning Model Achieves 97.97% Accuracy in Earthquake Prediction for Los Angeles
STATESBORO, Ga., Oct. 25, 2024 (GLOBE NEWSWIRE) — Cemil Emre Yavas and his research team have achieved a remarkable 97.97% accuracy in earthquake prediction for Los Angeles, a high-risk seismic
Andretti Acquisition Corp. II Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 28, 2024
New York, NY, Oct. 25, 2024 (GLOBE NEWSWIRE) — Andretti Acquisition Corp. II (Nasdaq: POLEU) (the “Company”) announced today that, commencing October 28, 2024, holders of the units sold in
SIMPPLE LTD. Announces Receipt of Nasdaq Staff Determination Letter
Singapore, Oct. 25, 2024 (GLOBE NEWSWIRE) — SIMPPLE LTD. (Nasdaq: SPPL) (the “Company” or “SIMPPLE”), an advanced technology solution provider in the emerging property-technology (“PropTech”) space, today announced that on